These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18550372)

  • 1. Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold.
    Sharma S; Rodriguez AL; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4098-101. PubMed ID: 18550372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of molecular switches that modulate modes of metabotropic glutamate receptor subtype 5 (mGlu5) pharmacology in vitro and in vivo within a series of functionalized, regioisomeric 2- and 5-(phenylethynyl)pyrimidines.
    Sharma S; Kedrowski J; Rook JM; Smith RL; Jones CK; Rodriguez AL; Conn PJ; Lindsley CW
    J Med Chem; 2009 Jul; 52(14):4103-6. PubMed ID: 19537763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators.
    Niswender CM; Lebois EP; Luo Q; Kim K; Muchalski H; Yin H; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5626-30. PubMed ID: 18793851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses.
    Chen Y; Nong Y; Goudet C; Hemstapat K; de Paulis T; Pin JP; Conn PJ
    Mol Pharmacol; 2007 May; 71(5):1389-98. PubMed ID: 17303702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in the development of allosteric modulators of mGluR5.
    Rodriguez AL; Williams R
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):715-22. PubMed ID: 17987523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.
    Bridges TM; Brady AE; Kennedy JP; Daniels RN; Miller NR; Kim K; Breininger ML; Gentry PR; Brogan JT; Jones CK; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5439-42. PubMed ID: 18805692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and SAR of novel mGluR5 non-competitive antagonists not based on an MPEP chemotype.
    Rodriguez AL; Williams R; Zhou Y; Lindsley SR; Le U; Grier MD; Weaver CD; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3209-13. PubMed ID: 19443219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization.
    Duplantier AJ; Efremov I; Candler J; Doran AC; Ganong AH; Haas JA; Hanks AN; Kraus KG; Lazzaro JT; Lu J; Maklad N; McCarthy SA; O'Sullivan TJ; Rogers BN; Siuciak JA; Spracklin DK; Zhang L
    Bioorg Med Chem Lett; 2009 May; 19(9):2524-9. PubMed ID: 19328692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators.
    Rodriguez AL; Nong Y; Sekaran NK; Alagille D; Tamagnan GD; Conn PJ
    Mol Pharmacol; 2005 Dec; 68(6):1793-802. PubMed ID: 16155210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA.
    Zhao Z; Wisnoski DD; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Wittman M; Ha SN; Schaffhauser H; Sur C; Pettibone DJ; Duggan ME; Conn PJ; Hartman GD; Lindsley CW
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1386-91. PubMed ID: 17210250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, SAR and unanticipated pharmacological profiles of analogues of the mGluR5 ago-potentiator ADX-47273.
    Engers DW; Rodriguez AL; Williams R; Hammond AS; Venable D; Oluwatola O; Sulikowski GA; Conn PJ; Lindsley CW
    ChemMedChem; 2009 Apr; 4(4):505-11. PubMed ID: 19197923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutic agents.
    Rocher JP; Bonnet B; Boléa C; Lütjens R; Le Poul E; Poli S; Epping-Jordan M; Bessis AS; Ludwig B; Mutel V
    Curr Top Med Chem; 2011; 11(6):680-95. PubMed ID: 21261592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
    Chen Y; Goudet C; Pin JP; Conn PJ
    Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5).
    Williams DL; Lindsley CW
    Curr Top Med Chem; 2005; 5(9):825-46. PubMed ID: 16178729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-lead.
    Williams R; Niswender CM; Luo Q; Le U; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2009 Feb; 19(3):962-6. PubMed ID: 19097893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: unexpected 'molecular switch' from a closely related mGlu4 positive allosteric modulator.
    Utley T; Haddenham D; Salovich JM; Zamorano R; Vinson PN; Lindsley CW; Hopkins CR; Niswender CM
    Bioorg Med Chem Lett; 2011 Dec; 21(23):6955-9. PubMed ID: 22030026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5.
    O'Brien JA; Lemaire W; Chen TB; Chang RS; Jacobson MA; Ha SN; Lindsley CW; Schaffhauser HJ; Sur C; Pettibone DJ; Conn PJ; Williams DL
    Mol Pharmacol; 2003 Sep; 64(3):731-40. PubMed ID: 12920211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4).
    Williams R; Johnson KA; Gentry PR; Niswender CM; Weaver CD; Conn PJ; Lindsley CW; Hopkins CR
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4967-70. PubMed ID: 19640716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituent effects of N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides on positive allosteric modulation of the metabotropic glutamate-5 receptor in rat cortical astrocytes.
    de Paulis T; Hemstapat K; Chen Y; Zhang Y; Saleh S; Alagille D; Baldwin RM; Tamagnan GD; Conn PJ
    J Med Chem; 2006 Jun; 49(11):3332-44. PubMed ID: 16722652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medications.
    Iso Y; Grajkowska E; Wroblewski JT; Davis J; Goeders NE; Johnson KM; Sanker S; Roth BL; Tueckmantel W; Kozikowski AP
    J Med Chem; 2006 Feb; 49(3):1080-100. PubMed ID: 16451073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.